Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Hirth currently holds 17,500 shares of Aligos Therapeutics, Inc. (ALGS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Hirth has been a net neutral trader of ALGS stock. They have purchased $0 and sold $0 worth of shares.
Peter Hirth's most recent insider trade was on Oct 8, 2026, when they sold 17,500 shares at $0.00 per share.
Peter Hirth serves as Executive at Aligos Therapeutics, Inc. (ALGS). They have executed 9 insider transactions totaling $0 over their tenure at the company.
Peter Hirth holds the position of Executive at Aligos Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Peter Hirth has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Peter Hirth was on Oct 8, 2026, when they purchased $0 worth of TRXB shares. This transaction involved 17,500 shares at N/A per share.
Peter Hirth currently owns 17,500 shares of Aligos Therapeutics, Inc. (ALGS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Hirth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Hirth has 9 Form 4 filings on record as an insider at Aligos Therapeutics, Inc..
Set alerts for Peter Hirth and 40,000+ other insiders.